Levels of ADAM10 are reduced in Alzheimer’s disease CSF

被引：0
作者：
Aitana Sogorb-Esteve
María-Salud García-Ayllón
Johan Gobom
Jordi Alom
Henrik Zetterberg
Kaj Blennow
Javier Sáez-Valero
机构：
[1] Universidad Miguel Hernández-CSIC,Instituto de Neurociencias de Alicante
[2] Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED),Servicio de Neurología, Hospital General Universitario de Elche
[3] Unidad de Investigación,Clinical Neurochemistry Laboratory
[4] Hospital General Universitario de Elche,Department of Neuroscience and Physiology
[5] Fundación para el Fomento de la Investigación Sanitaria Biomédica de la Comunidad Valenciana (FISABIO),Department of Molecular Neuroscience
[6] Fundación para el Fomento de la Investigación Sanitaria Biomédica de la Comunidad Valenciana (FISABIO),undefined
[7] Sahlgrenska University Hospital,undefined
[8] the Sahlgrenska Academy at the University of Gothenburg,undefined
[9] UCL Institute of Neurology,undefined
[10] UK Dementia Research Institute at UCL,undefined
来源：
Journal of Neuroinflammation | / 15卷
关键词：
Prodomain; Amyloid Precursor Protein (APP); ADAM10 Levels; ADAM10 Antibody; Ectodomain Antibody;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[21]   LDLR-related protein 10 (LRP10) regulates amyloid precursor protein (APP) trafficking and processing: evidence for a role in Alzheimer’s disease [J].
Julie Brodeur ;
Caroline Thériault ;
Mélissa Lessard-Beaudoin ;
Alexandre Marcil ;
Sophie Dahan ;
Christine Lavoie .
Molecular Neurodegeneration, 7
[22]   Association between the characteristics of metabolic syndrome and Alzheimer's disease [J].
Yang, Hui-Ting ;
Sheen, Yi-Jing ;
Kao, Chuen-Der ;
Chang, Chin-An ;
Hu, Ya-Chun ;
Lin, Jiann-Liang .
METABOLIC BRAIN DISEASE, 2013, 28 (04) :597-604
[23]   Familial Alzheimer's disease. Case-history [J].
Okacova, L ;
Kanovsky, P .
CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 1995, 58 (06) :294-296
[24]   Association between the characteristics of metabolic syndrome and Alzheimer’s disease [J].
Hui-Ting Yang ;
Yi-Jing Sheen ;
Chuen-Der Kao ;
Chin-An Chang ;
Ya-Chun Hu ;
Jiann-Liang Lin .
Metabolic Brain Disease, 2013, 28 :597-604
[25]   Biological markers of amyloid β-related mechanisms in Alzheimer's disease [J].
Hampel, Harald ;
Shen, Yong ;
Walsh, Dominic M. ;
Aisen, Paul ;
Shaw, Les M. ;
Zetterberg, Henrik ;
Trojanowski, John Q. ;
Blennow, Kaj .
EXPERIMENTAL NEUROLOGY, 2010, 223 (02) :334-346
[26]   RAGE-Mediated Effects of Formaldehyde in Alzheimer's Disease [J].
Mikhailov, Ilya G. ;
Mikhailova, Milana S. ;
Shuvaev, Anton N. ;
Gorina, Yana V. ;
Belozor, Olga S. .
BIOCHEMISTRY-MOSCOW, 2025, 90 (03) :334-348
[27]   Is anti-cholinesterase therapy of Alzheimer's disease delaying progression? [J].
Giacobini, E .
AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2001, 13 (03) :247-254
[28]   Visualizing interaction of proteins relevant to Alzheimer's disease in intact cells [J].
Thomas, Anne V. ;
Berezovska, Oksana ;
Hyman, Bradley T. ;
von Arnim, Christine A. F. .
METHODS, 2008, 44 (04) :299-303
[29]   Is anti-cholinesterase therapy of Alzheimer’s disease delaying progression? [J].
E. Giacobini .
Aging Clinical and Experimental Research, 2001, 13 :247-254
[30]   Spatial patterns of β-amyloid (Aβ) deposits in familial and sporadic Alzheimer's disease [J].
Armstrong, Richard A. .
FOLIA NEUROPATHOLOGICA, 2011, 49 (03) :153-161
12345